Recent news on Isovue

The Latest Head-to-Head Clinical Study Comparing the Risk of CIN ...  Nov 1, 2006
PRINCETON, NJ--(BUSINESS WIRE)--Oct 31, 2006 - The results of a clinical study comparing Isovue(R)-370 (iopamidol injection), marketed by Bracco Diagnostics Inc ... -PharmaLive.com (press release), TCT: Low-Osmolar Contrast Agents Don't Increase Nephropathy Risk  Oct 26, 2006
That finding emerged from a pair of trials that compared the low-osmolar contrast agents Isovue (iopamidol) and Hexabrix (ioxaglate).with Visipaque in high ... -MedPage Today,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional